Company profile
Beactica Therapeutics AB company profile
Beactica Therapeutics AB is a precision oncology company committed to the fight against cancer. The company is advancing a pipeline of novel small molecule therapeutics to treat genetically defined cancers with significant unmet clinical need. Beactica’s approach is centered around targeting disease proteins with synthetic lethality vulnerabilities by applying its molecular interaction-based drug discovery engine to generate novel small molecule across synergistic modalities, including allosteric modulators and targeted protein degraders (PROTACs). Beactica deliver value to patients and shareholders by advancing its programmes into early clinical trials.
Business identity
- Website
- http://www.beactica.com/
- Phone number
- 46 18 56 08 80
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Revenue range
- $0-$1M
- Founded
- 2006-01-01, Year
Headquarters
- Headquarters
- Kholbon, Zabaykalskiy (Transbaikal) Kray, Russia
- Postal code
- 754 50
- Country code
- RU
- Continent
- Europe